Skip to ContentSkip to Navigation
How to find us drs. H.D. Hoving

Publications

Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone

Early F-18-FDHT PET/CT as a predictor of treatment response in mCRPC treated with enzalutamide.

F-18-FDHT PET/CT as a predictor of treatment response in mCRPC treated with enzalutamide

EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study

CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy

An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting

Application of (99m)Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7-14) SPECT/CT in prostate cancer patients A first-in-man study

Preclinical Evaluation of a Novel In-111-Labeled Bombesin Homodimer for Improved Imaging of GRPR-Positive Prostate Cancer

Read more